Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-0.58 Insider Own0.10% Shs Outstand339.00M Perf Week5.30%
Market Cap54.51B Forward P/E9.83 EPS next Y16.35 Insider Trans3.65% Shs Float336.25M Perf Month18.55%
Income-205.90M PEG- EPS next Q4.16 Inst Own88.40% Short Float1.45% Perf Quarter-15.16%
Sales16.03B P/S3.40 EPS this Y-543.10% Inst Trans0.04% Short Ratio1.77 Perf Half Y-6.64%
Book/sh207.99 P/B0.77 EPS next Y-1.12% ROA2.00% Target Price206.29 Perf Year-14.54%
Cash/sh3.57 P/C45.05 EPS next 5Y5.68% ROE3.10% 52W Range125.84 - 197.00 Perf YTD20.30%
Dividend2.88 P/FCF11.37 EPS past 5Y7.18% ROI-2.10% 52W High-18.38% Beta1.54
Dividend %1.79% Quick Ratio0.80 Sales past 5Y21.90% Gross Margin86.40% 52W Low27.77% ATR4.38
Employees17800 Current Ratio0.90 Sales Q/Q-3.00% Oper. Margin16.30% RSI (14)70.80 Volatility2.43% 2.99%
OptionableYes Debt/Eq0.33 EPS Q/Q99.10% Profit Margin13.80% Rel Volume0.86 Prev Close157.80
ShortableYes LT Debt/Eq0.32 EarningsJan 29 BMO Payout42.60% Avg Volume2.75M Price160.79
Recom2.00 SMA2012.21% SMA507.17% SMA200-4.26% Volume2,362,633 Change1.89%
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Jan-23-19 08:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XPO, IMMU, AXGN and AGN GlobeNewswire
04:00PM  SHAREHOLDER ALERT: WBT GSKY GS AGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
01:49PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
12:36PM  CLASS ACTION UPDATE for GS, XRAY and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:18AM  Better Buy: CRISPR Therapeutics vs. Editas Medicine Motley Fool
Jan-22-19 03:27PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NVDA, AGN, DXC and ALKS GlobeNewswire
01:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline - AGN ACCESSWIRE
09:09AM  Aurinia's Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial Benzinga
Jan-21-19 01:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 GlobeNewswire
Jan-20-19 08:59AM  Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes? Motley Fool
Jan-18-19 10:50PM  ALLERGAN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN Business Wire
06:50PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
Jan-17-19 01:54PM  Final trades: Intuitive Surgical, Allergan, Starbucks & S... CNBC Videos
12:27PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
Jan-16-19 09:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN ACCESSWIRE
12:26PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
10:05AM  Ironwood's (IRWD) Linzess Gets Approval in China for IBS-C Zacks
Jan-15-19 02:33PM  SHAREHOLDER ALERT: GS XRAY NVDA AGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
02:09PM  Drug companies greet 2019 with U.S. price hikes Reuters
07:45AM  CoolSculpting® and Sonja Morgan Partner To Get Real About Self-Care PR Newswire
Jan-14-19 04:22PM  CLASS ACTION UPDATE for NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 GlobeNewswire
Jan-13-19 02:01PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XRAY, NVDA and AGN GlobeNewswire
01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline - AGN ACCESSWIRE
Jan-11-19 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN GlobeNewswire
07:02PM  Cramer's Exec Cut: The biggest names in healthand Apple... CNBC Videos
06:59PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
03:06PM  7 Pharmaceutical Stocks That Just Raised Prices This Year InvestorPlace
01:06PM  SHAREHOLDER ALERT: YRCW AGN ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:51AM  Health Canada places restrictions on Allergan's fibroid treatment Esmya Reuters
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
Jan-10-19 06:05PM  Here's Why Editas Medicine Lost 16.6% in December Motley Fool
01:53PM  CLASS ACTION UPDATE for NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:40AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
Jan-09-19 06:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN ACCESSWIRE
01:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YRCW, AGN and YRIV GlobeNewswire
09:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
08:38AM  Allergan Must Prove Itself With Signs of More Aggressive Buying TheStreet.com
Jan-08-19 06:59PM  Cramer Remix: Not so fastthe Fed might not be done with its rate hikes yet CNBC
01:08PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GS, XRAY and AGN GlobeNewswire
09:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 GlobeNewswire
06:01AM  Bull of the Day: Editas Medicine (EDIT) Zacks
05:01AM  Allergan joins biotech swarm in Kendall Square with R&D hub American City Business Journals
Jan-07-19 12:20PM  SHAREHOLDER ALERT: GS XRAY AGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:50AM  Ironwood to Get New CEO, Current CEO to Head Latest Spinoff Zacks
07:45AM  Allergan Announces Positive 3-Month Topline Results from Second Phase 3 Study of Bimatoprost SR (Sustained-Release) Implant for Lowering Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension PR Newswire
07:30AM  Allergan to Establish R&D Presence in Cambridge, Massachusetts PR Newswire
07:02AM  5 Things to Watch for at the JPMorgan Healthcare Conference Investopedia
07:00AM  Today's Research Reports on Trending Tickers: AbbVie and Allergan ACCESSWIRE
Jan-05-19 09:00AM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
Jan-04-19 10:50PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN PR Newswire
10:10AM  Why Allergan (AGN) Could Beat Earnings Estimates Again Zacks
Jan-03-19 10:27AM  Ironwood/Allergan Settle Linzess Patent Litigation With Mylan Zacks
09:55AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
07:45AM  New Data Published in the International Journal of Neuropsychopharmacology Support that Rapastinel May Produce Rapid and Sustained Antidepressant Effects Through a Potentially Novel Mechanism of Action PR Newswire
07:36AM  The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen Benzinga
07:30AM  Allergan to Report Fourth Quarter and Full Year 2018 Earnings and Host Conference Call and Webcast PR Newswire
07:09AM  10 Bargain Stocks Amid Market's Wreckage Investopedia
06:00AM  Healthcare: Specter of ACA Repeal Hangs Over Fairly Valued Sector Morningstar
Jan-02-19 07:53PM  Corrections & Amplifications The Wall Street Journal
07:38PM  Corrections & Amplifications The Wall Street Journal
06:19PM  Drugmakers ring in the new year by hiking prices on hundreds of drugs Fox Business Videos
04:28PM  Biopharmas Restrained In Drug Pricing For 2019 With These Exceptions Investor's Business Daily
02:56PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN GlobeNewswire
02:56PM  CLASS ACTION UPDATE for YOGA, IMMU and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:53PM  Drug companies greet 2019 with U.S. price hikes Reuters
01:29PM  Drug companies greet 2019 with U.S. price hikes Reuters
10:27AM  Drug Prices Set to Rise 6.3% in 2019, But Will They Stay Up? Investopedia
09:36AM  Americans facing higher drug prices in 2019 Fox Business Videos
07:18AM  Drug price hikes ahead despite Trump's political pressure? Fox Business Videos
07:00AM  Market Morning: Stocks Lurch, Drug Price Hikes, Trump Caves, China Threatens Market Exclusive
Jan-01-19 09:13PM  Drugmakers Raise Prices on Hundreds of Medicines The Wall Street Journal
08:33PM  [$$] Drugmakers Raise Prices on Hundreds of Medicines The Wall Street Journal
07:35PM  [$$] Drugmakers Raise Prices on Hundreds of Medicines The Wall Street Journal
Dec-31-18 10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 GlobeNewswire
Dec-30-18 10:20AM  Stocks That Fell to 3-Year Lows in the Week of Dec. 28 GuruFocus.com
08:39AM  The $35 billion race to cure a liver disease that affects 30 million Americans CNBC
Dec-28-18 09:29AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
07:00AM  CLASS ACTION UPDATE for XPO, TDOC and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Dec-27-18 11:15AM  Allergan Shareholder Alert: Block & Leviton LLP Reminds Investors of Securities Class Action Filed Against Allergan plc ("AGN"); Investors Are Encouraged to Contact the Firm ACCESSWIRE
10:35AM  Yahoo Finance: Market Movers - Jan 02 Yahoo Finance Video
10:27AM  SHAREHOLDER ALERT: NVDA AGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Dec-26-18 10:52PM  Pomerantz Law Firm Announces the Filing of a Class Action against Allergan plc. and Certain Officers AGN GlobeNewswire
05:30PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Allergan plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 19, 2019 AGN GlobeNewswire
03:34PM  2019 will be robust year for health care stocks, says Fre... CNBC Videos
01:37PM  Final trades: Amazon, Visa, H&E Equipment & Allergan CNBC Videos
09:28AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
Dec-24-18 10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline: February 19, 2019 GlobeNewswire
07:30AM  Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-18 09:01AM  Challenges Facing Health Care Stocks in 2019 Investopedia
Dec-21-18 09:47AM  Securities Class Action Against Allergan plc ("AGN") Filed By Block & Leviton LLP; Investors Are Encouraged to Contact the Firm PR Newswire
Dec-20-18 10:46AM  The Charts of Allergan Look Very Bearish With New Lows Made Yesterday TheStreet.com
10:18AM  Allergan Drops, Stops Textured Breast Implant Sales in Europe Zacks
07:05AM  Today's Research Reports on Trending Tickers: Allergan and Teva Pharmaceutical ACCESSWIRE
02:52AM  [$$] Pharma Giants Plan Drug Price Hike: Report The Wall Street Journal
Dec-19-18 08:08PM  Major pharma companies plan to raise drug prices in January: report MarketWatch -6.95%
07:48PM  Exclusive: Big Pharma returning to U.S. price hikes in January after pause Reuters
06:59PM  Stocks - Dow Slumps as Less Dovish Fed Triggers Selloff Investing.com
04:52PM  GlaxoSmithKline and General Mills climb while FedEx drops Associated Press
04:34PM  Why FedEx, Allergan, and FTS International Slumped Today Motley Fool
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, and anti-infective therapeutic categories. It also provides breast implants and tissue expanders; RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis; ocular implants; and Kybella, a non-surgical treatment for submental fullness. In addition, the company develops therapies for non-alcoholic steatohepatitis and other liver diseases; treatments for neurodegenerative disorders, including Alzheimer's disease; small molecule therapeutics that target inflammatory and fibrotic diseases; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and licensing agreements with Assembly Biosciences, Inc. MedImmune, and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM
Hilado Maria TeresaExecutive Vice PresidentMar 15Buy167.39895149,81426,530Mar 19 09:36 AM
WALSH MATTHEW MEVP, Chief Financial OfficerMar 08Buy153.961,000153,96025,416Mar 08 10:44 AM
SAUNDERS BRENT LChairman, President and CEOMar 08Buy152.533,300503,349180,931Mar 08 10:25 AM
Boccuzi Joseph HDirectorMar 05Buy143.42900129,0781,862Mar 09 04:31 PM
WALSH MATTHEW MEVP, Chief Financial OfficerFeb 21Buy160.942,000321,88024,416Feb 22 04:25 PM
Meury WilliamChief Commercial OfficerFeb 14Option Exercise63.1723,6131,491,73778,600Feb 16 05:10 PM
Meury WilliamChief Commercial OfficerFeb 14Sale160.6258,8799,457,36919,721Feb 16 05:10 PM